Posted inBristol Myers Squibb Company Drugs (Pharmaceuticals) Food and Drug Administration Karuna Therapeutics Inc Mental Health and Disorders Mergers, Acquisitions and Divestitures
Bristol Myers to Acquire the Drugmaker Karuna for $14 Billion
The deal is a bet on the growing market for psychiatric and neurological drugs.